China Shijiazhuang Pharmaceutical Group Co., Ltd. (CSPC) was incorporated by Hebei Pharmaceutical Corporation, Shijiazhuang No. 1 Pharmaceutical Group Co., Ltd. and other two companies on Aug 21, 1997. It's the first mega pharmaceutical enterprise jointly established by big pharmaceutical enterprises in the medicine industry of China, and it's also one of the pillar enterprise group of Hebei Province. Its key products include antibiotic, vitamin, cardiovascular and cerebrovascular medicine, antipyretic and analgesic drug and respiratory drug, etc, six series in total and nearly 1,000 varieties, and penicillin series and vitamin series are its dominant products.

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Manufacturer/Innovator

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information

Address

Telephone

Website

View All Contact Info

Top Products

Cefradine Caps

Hebei Huarong Pharmaceutical, Co. Ltd.

Request Info

Cephatexin Caps

Hebei Huarong Pharmaceutical, Co. Ltd.

Request Info

Indomethacin Caps

Hebei Huarong Pharmaceutical, Co. Ltd.

Request Info

Lincomycin Hydrochloride Caps

Hebei Huarong Pharmaceutical, Co. Ltd.

Request Info

Categories affiliated with Hebei Huarong Pharmaceutical, Co. Ltd.